Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Different Effects of Metformin on the Hypothalamic-Pituitary-Thyroid Axis in Bromocriptine- and Cabergoline-treated Patients with Hashimoto's Thyroiditis and Glucose Metabolism Abnormalities.

Krysiak R, Okrzesik J, Okopien B.

Exp Clin Endocrinol Diabetes. 2015 Oct;123(9):561-6. doi: 10.1055/s-0035-1564073. Epub 2015 Sep 15.

PMID:
26372847
2.

The Effect of Metformin on Hypothalamic-Pituitary-Thyroid Axis Activity in Women with Interferon-Induced Hypothyroidism: A Pilot Study.

Krysiak R, Szkrobka W, Okopien B.

Exp Clin Endocrinol Diabetes. 2016 Feb;124(2):71-6. doi: 10.1055/s-0035-1565207. Epub 2016 Feb 19.

PMID:
26895275
3.

Sex-dependent effect of metformin on hypothalamic-pituitary-thyroid axis activity in patients with subclinical hypothyroidism.

Krysiak R, Szkróbka W, Okopień B.

Pharmacol Rep. 2016 Dec;68(6):1115-1119. doi: 10.1016/j.pharep.2016.07.002. Epub 2016 Jul 16.

PMID:
27588386
4.

The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and amiodarone-induced hypothyroidism.

Krysiak R, Gilowska M, Szkróbka W, Okopień B.

Pharmacol Rep. 2016 Apr;68(2):490-4. doi: 10.1016/j.pharep.2015.11.010. Epub 2015 Dec 15.

PMID:
26922558
5.

Effect of Metformin on Hypothalamic-Pituitary-Thyroid Axis Activity in Elderly Antipsychotic-Treated Women With Type 2 Diabetes and Subclinical Hypothyroidism: A Preliminary Study.

Krysiak R, Szkróbka W, Okopień B.

J Clin Pharmacol. 2018 May;58(5):586-592. doi: 10.1002/jcph.1048. Epub 2017 Dec 18.

PMID:
29251783
6.

The effect of metformin on the hypothalamic-pituitary-thyroid axis in women with polycystic ovary syndrome and subclinical hypothyroidism.

Krysiak R, Okopien B.

J Clin Pharmacol. 2015 Jan;55(1):45-9. doi: 10.1002/jcph.373. Epub 2014 Aug 5.

PMID:
25079765
7.

Alternative Treatment Strategies in Women Poorly Tolerating Moderate Doses of Bromocriptine.

Krysiak R, Szkróbka W, Okopień B.

Exp Clin Endocrinol Diabetes. 2017 Jun;125(6):360-364. doi: 10.1055/s-0042-123041. Epub 2017 Jan 10.

PMID:
28073129
8.
9.

The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and subclinical hyperthyroidism.

Krysiak R, Szkrobka W, Okopien B.

Exp Clin Endocrinol Diabetes. 2015 Apr;123(4):205-8. doi: 10.1055/s-0034-1398621. Epub 2015 Feb 6.

PMID:
25658660
10.

The effect of statin therapy on thyroid autoimmunity in patients with Hashimoto's thyroiditis: A pilot study.

Krysiak R, Kowalcze K, Okopień B.

Pharmacol Rep. 2016 Apr;68(2):429-33. doi: 10.1016/j.pharep.2015.11.005. Epub 2015 Nov 25.

PMID:
26922549
11.

Moderate-dose simvastatin therapy potentiates the effect of vitamin D on thyroid autoimmunity in levothyroxine-treated women with Hashimoto's thyroiditis and vitamin D insufficiency.

Krysiak R, Szkróbka W, Okopień B.

Pharmacol Rep. 2018 Feb;70(1):93-97. doi: 10.1016/j.pharep.2017.07.019. Epub 2017 Jul 27.

PMID:
29331793
12.

Different effects of cabergoline and bromocriptine on metabolic and cardiovascular risk factors in patients with elevated prolactin levels.

Krysiak R, Okopien B.

Basic Clin Pharmacol Toxicol. 2015 Mar;116(3):251-6. doi: 10.1111/bcpt.12307. Epub 2014 Sep 11.

13.

The Effect of Vitamin D on Thyroid Autoimmunity in Levothyroxine-Treated Women with Hashimoto's Thyroiditis and Normal Vitamin D Status.

Krysiak R, Szkróbka W, Okopień B.

Exp Clin Endocrinol Diabetes. 2017 Apr;125(4):229-233. doi: 10.1055/s-0042-123038. Epub 2017 Jan 10.

PMID:
28073128
14.

The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated Hypercholesterolemia.

Krysiak R, Gilowski W, Szkrobka W, Okopien B.

Cardiovasc Ther. 2015 Oct;33(5):282-7. doi: 10.1111/1755-5922.12143.

PMID:
26146893
15.

The Effect of Metformin on Serum Gonadotropin Levels in Postmenopausal Women with Diabetes and Prediabetes: A Pilot Study.

Krysiak R, Szkróbka W, Okopień B.

Exp Clin Endocrinol Diabetes. 2018 Nov;126(10):645-650. doi: 10.1055/a-0584-0006. Epub 2018 Mar 12.

PMID:
29529690
16.

The effect of metformin on prolactin levels in patients with drug-induced hyperprolactinemia.

Krysiak R, Kowalcze K, Szkrobka W, Okopien B.

Eur J Intern Med. 2016 May;30:94-98. doi: 10.1016/j.ejim.2016.01.015. Epub 2016 Feb 5.

PMID:
26858210
17.

Positive prolactin response to bromocriptine in 2 patients with cabergoline-resistant prolactinomas.

Iyer P, Molitch ME.

Endocr Pract. 2011 May-Jun;17(3):e55-8. doi: 10.4158/EP10369.CR.

PMID:
21324816
18.

Prolactin-lowering effect of acute and once weekly repetitive oral administration of cabergoline at two dose levels in hyperprolactinemic patients.

Mattei AM, Ferrari C, Baroldi P, Cavioni V, Paracchi A, Galparoli C, Romano C, Spellecchia D, Gerevini G, Crosignani PG.

J Clin Endocrinol Metab. 1988 Jan;66(1):193-8.

PMID:
3275684
19.

Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients.

Verhelst J, Abs R, Maiter D, van den Bruel A, Vandeweghe M, Velkeniers B, Mockel J, Lamberigts G, Petrossians P, Coremans P, Mahler C, Stevenaert A, Verlooy J, Raftopoulos C, Beckers A.

J Clin Endocrinol Metab. 1999 Jul;84(7):2518-22.

20.

Lymphocyte-suppressing and systemic anti-inflammatory effects of high-dose metformin in simvastatin-treated patients with impaired fasting glucose.

Krysiak R, Okopien B.

Atherosclerosis. 2012 Dec;225(2):403-7. doi: 10.1016/j.atherosclerosis.2012.09.034. Epub 2012 Oct 12.

PMID:
23107042

Supplemental Content

Support Center